About Quanta Dialysis Technologies
Quanta Dialysis Technologies is a company based in Alcester (United Kingdom) founded in 2008 by Clive Henry Buckberry. It operates as a HealthTech, and Direct-to-Consumer (D2C). Quanta Dialysis Technologies has raised $432.84 million across 9 funding rounds from investors including Air Liquide, BlackRock and IMI. The company has 100 employees as of December 31, 2020. Quanta Dialysis Technologies offers products and services including Quanta Dialysis System and Trinal Kidney Therapy (TKT). Quanta Dialysis Technologies operates in a competitive market with competitors including Fresenius, Outset Medical, Hemotune, Diality and NxStage, among others.
- Headquarter Alcester, United Kingdom
- Employees 100 as on 31 Dec, 2020
- Founders Clive Henry Buckberry
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Quanta Dialysis Technologies Inc.
-
Annual Revenue
$1.4 M (USD)39as on Dec 31, 2022
-
Net Profit
$-54.63 M (USD)-82as on Dec 31, 2022
-
EBITDA
$-60.51 M (USD)-75as on Dec 31, 2022
-
Total Equity Funding
$432.84 M (USD)
in 9 rounds
-
Latest Funding Round
$60 M (USD), Series E
Nov 18, 2024
-
Investors
Air Liquide
& 27 more
-
Employee Count
100
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Quanta Dialysis Technologies
Quanta Dialysis Technologies offers a comprehensive portfolio of products and services, including Quanta Dialysis System and Trinal Kidney Therapy (TKT). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A compact system for advanced kidney dialysis therapies.
Innovative therapy combining multiple dialysis treatment modalities.
Unlock access to complete
Unlock access to complete
Funding Insights of Quanta Dialysis Technologies
Quanta Dialysis Technologies has successfully raised a total of $432.84M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $60 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series E — $60.0M
-
First Round
First Round
(17 Sep 2009)
- Investors Count 28
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series E - Quanta Dialysis Technologies | Valuation | Novo Holdings | |
| Jun, 2021 | Amount | Series D - Quanta Dialysis Technologies | Valuation | Novo Holdings | |
| Jul, 2019 | Amount | Series C - Quanta Dialysis Technologies | Valuation | b2venture , Wellington Partners Venture Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Quanta Dialysis Technologies
Quanta Dialysis Technologies has secured backing from 28 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Air Liquide, BlackRock and IMI. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Venture capital is provided to innovative startups by b2venture.
|
Founded Year | Domain | Location | |
|
Holding company investing in insurance, asset management, technology, mobility, sports, music, real estate, and consumer sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Quanta Dialysis Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Quanta Dialysis Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quanta Dialysis Technologies Comparisons
Competitors of Quanta Dialysis Technologies
Quanta Dialysis Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fresenius, Outset Medical, Hemotune, Diality and NxStage, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
System-critical products and services for healthcare therapies are provided.
|
|
| domain | founded_year | HQ Location |
Hemodialysis machines with touchscreen displays are provided for medical use.
|
|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Developer of portable hemodialysis device
|
|
| domain | founded_year | HQ Location |
Home and critical care dialysis systems
|
|
| domain | founded_year | HQ Location |
Blood purification equipment for kidney failure patients is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quanta Dialysis Technologies
Frequently Asked Questions about Quanta Dialysis Technologies
When was Quanta Dialysis Technologies founded?
Quanta Dialysis Technologies was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Quanta Dialysis Technologies located?
Quanta Dialysis Technologies is headquartered in Alcester, United Kingdom. It is registered at Alcester, Warwickshire, United Kingdom.
Is Quanta Dialysis Technologies a funded company?
Quanta Dialysis Technologies is a funded company, having raised a total of $432.84M across 9 funding rounds to date. The company's 1st funding round was a Series C of $47.03M, raised on Sep 17, 2009.
How many employees does Quanta Dialysis Technologies have?
As of Dec 31, 2020, the latest employee count at Quanta Dialysis Technologies is 100.
What is the annual revenue of Quanta Dialysis Technologies?
Annual revenue of Quanta Dialysis Technologies is $1.4M as on Dec 31, 2022.
What does Quanta Dialysis Technologies do?
Quanta Dialysis Technologies is engaged in developing advanced dialysis systems for kidney care. The company operates in the healthcare sector, specializing in medical devices. Its flagship product, the Quanta Dialysis System, offers versatile treatment options across various care settings. Solutions are designed to enhance efficiency and flexibility for healthcare providers and patients. The focus is on delivering innovative care through compact, user-friendly technology.
Who are the top competitors of Quanta Dialysis Technologies?
Quanta Dialysis Technologies's top competitors include Outset Medical, Fresenius and Diality.
What products or services does Quanta Dialysis Technologies offer?
Quanta Dialysis Technologies offers Quanta Dialysis System and Trinal Kidney Therapy (TKT).
Who are Quanta Dialysis Technologies's investors?
Quanta Dialysis Technologies has 28 investors. Key investors include Air Liquide, BlackRock, IMI, Orlando Health, and Aliada.
What is Quanta Dialysis Technologies's valuation?
The valuation of Quanta Dialysis Technologies is $103.2M as of Jun 2017.